LAPATINIB WITH CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED NSCLC IN NEVER SMOKERS OR SELDOM SMOKERS

被引：0
|
作者：
Pandey, R. [1 ]
Dey, S. [1 ]
Mukhopadhyay, A. [1 ]
机构：
[1] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata, India
来源：
LUNG CANCER | 2009年 / 64卷
关键词：
D O I：
10.1016/S0169-5002(09)70254-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [1] PACLITAXEL AND CARBOPLATIN WITH OR WITHOUT LAPATINIB IN FIRST LINE TREATMENT OF ADVANCED NSCLC IN NEVER SMOKERS OR SELDOM SMOKERS
    Pandey, R.
    Dey, S.
    Bose, C. K.
    Mukhopadhyay, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 44 - 44
  • [2] Lapatinib as maintainence treatment after first line treatment of metastatic adenocarcinomas of lung in never smokers or seldom smokers
    Pandey, R.
    Dey, S.
    Bose, C.
    Mukhopadhyay, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 546 - 547
  • [3] Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers
    Lee, D
    Han, J
    Lee, E
    Kim, H
    Kim, H
    Hong, E
    Lee, J
    LUNG CANCER, 2005, 49 : S38 - S38
  • [4] Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers
    Lee, DH
    Han, JY
    Lee, HG
    Lee, JJ
    Lee, EK
    Kim, HY
    Kim, HK
    Hong, EK
    Lee, JS
    CLINICAL CANCER RESEARCH, 2005, 11 (08) : 3032 - 3037
  • [5] Ethnic Status and Socioeconomic Deprivation in Never Smokers Compared with Current Smokers with advanced NSCLC
    Gabriel, Lydia
    Bhosle, Jaishree
    Davidson, Michael
    Milner-Watts, Charlotte
    O'Brien, Mary
    LUNG CANCER, 2024, 190
  • [6] Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as a first-line therapy
    Lee, Young Joo
    Yoon, Kyong-Ah
    Lee, Jin Soo
    CANCER RESEARCH, 2011, 71
  • [7] Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy
    Lee, Young Joo
    Yoon, Kyong-Ah
    Han, Ji-Youn
    Kim, Heung Tae
    Yun, Tak
    Lee, Geon Kook
    Kim, Hyae Young
    Lee, Jin Soo
    CLINICAL CANCER RESEARCH, 2011, 17 (15) : 5179 - 5187
  • [8] Docetaxel and cisplatin as first-line chemotherapy in advanced NSCLC.
    Behera, D
    Aggarwal, AN
    Gupta, D
    Jindal, SK
    Sharma, SC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 705S - 705S
  • [9] NSCLC in never smokers: treatment outcome: a single institution experience
    Crino, Lucio
    Minotti, Vincenzo
    Meacci, Marialuisa
    Betti, Maura
    Molica, Carmen
    Ludovini, Vienna
    Pistola, Lorenza
    Tofanetti, Francesca R.
    Flacco, Antonella
    Chiari, Rita
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S675 - S676
  • [10] Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
    Andric, Zoran
    Galffy, Gabriella
    Dols, Manuel Cobo
    Szima, Barna
    Stojanovic, Goran
    Petrovic, Marina
    Felip, Enriqueta
    Baz, David Vicente
    Aix, Santiago Ponce
    Juan-Vidal, Oscar
    Szalai, Zsuzsanna
    Losonczy, Gyorgy
    Blanco, Antonio Calles
    Bernabe, Reyes
    Ledo, Gema Garcia
    Hernandez, Andres Aguilar
    Duecker, Klaus
    Zhou, Dongli
    Schroeder, Andreas
    Guezel, Guelseren
    Ciardiello, Fortunato
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
12345